阻碍口服吸入治疗抗体的障碍物
Thomas Sécher1,2, Nathalie Heuzé-Vourc'h1,2
1INSERM, Centre d'Etude des Pathologies Respiratoires, Tours, France.
Expert opinion on drug delivery
|August 23, 2023
概括
吸入治疗性抗体 (Abs) 对呼吸系统疾病具有前景. 克服肺部障碍是开发有效的吸入式AB疗法和改善患者治疗结果的关键.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药物运输 药物运输 药物运输
背景情况:
- 呼吸系统疾病构成了重大的全球健康挑战,由流行病和肺癌和炎症疾病的流行加剧.
- 治疗性抗体 (Abs) 是治疗呼吸系统疾病的一个有希望的途径.
- 通过空气道输送Abs可以增强其治疗效果.
研究的目的:
- 审查影响肺部吸入治疗性ABS的障碍.
- 讨论呼吸系统疾病病理学如何加剧这些障碍.
- 突出需要改进吸入AB配方和输送系统的需要.
主要方法:
- 关于吸入治疗抗体现有研究的文献综述.
- 分析肺系统中的物理和生物障碍.
- 检查呼吸道疾病中的病理变化,影响ABC分娩.
主要成果:
- 肺部的ABS输送途径未得到充分利用,只有有限的被批准的吸入ABS.
- 肺部的物理和生物障碍可能会阻碍AB的有效性.
- 疾病特异性的病理变化可能会进一步损害吸入式AB的性能.
结论:
- 开发有效的吸入式AB疗法需要通过优化配方-设备组合来解决交织的肺障碍.
- 需要进一步的研究和临床试验,以建立吸入式ABS作为呼吸道疾病的主流治疗方法.
- 应该专注于创建Ab-配方-设备组合,以获得最佳的沉积和治疗效果.
相关概念视频
Inhaled Medications
308
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
308
Drug Delivery: Miscellaneous Routes
380
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
380
Additional Routes of Drug Administration
2.8K
Choosing the appropriate route of drug administration is significantly influenced by two key factors: the therapeutic objectives and the inherent properties of the drug being used.
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
2.8K
Factors Influencing Drug Absorption: Presystemic Elimination
262
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
262
Drug Delivery: Enteral Route
503
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
503
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
342
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
342


